Variant report

Variant	rs73782572
Chromosome Location	chr6:160819978-160819979
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	EP300	chr6:160819854-160820108	Hela-S3	cervix:	n/a	n/a
2	MAFK	chr6:160819712-160820028	H1-hESC	embryonic stem cell:	n/a	chr6:160819852-160819867 chr6:160819852-160819863 chr6:160819853-160819873 chr6:160819851-160819865 chr6:160819852-160819863 chr6:160819853-160819864 chr6:160819852-160819868 chr6:160819853-160819864 chr6:160819857-160819866
3	MAFK	chr6:160819689-160820046	Hela-S3	cervix:	n/a	chr6:160819852-160819867 chr6:160819852-160819863 chr6:160819853-160819873 chr6:160819851-160819865 chr6:160819852-160819863 chr6:160819853-160819864 chr6:160819852-160819868 chr6:160819853-160819864 chr6:160819857-160819866
4	BATF	chr6:160819942-160820252	GM12878	blood:	n/a	n/a
5	STAT3	chr6:160819690-160820087	MCF10A-Er-Src	breast:	n/a	n/a
6	FOS	chr6:160819684-160820098	MCF10A-Er-Src	breast:	n/a	chr6:160819907-160819915 chr6:160819905-160819916 chr6:160819857-160819869 chr6:160819905-160819917 chr6:160819859-160819867
7	BATF	chr6:160819944-160820270	GM12878	blood:	n/a	n/a
8	FOS	chr6:160819720-160820087	MCF10A-Er-Src	breast:	n/a	chr6:160819907-160819915 chr6:160819905-160819916 chr6:160819857-160819869 chr6:160819905-160819917 chr6:160819859-160819867
9	STAT3	chr6:160819681-160820036	MCF10A-Er-Src	breast:	n/a	n/a
10	BACH1	chr6:160819771-160820032	H1-hESC	embryonic stem cell:	n/a	n/a
11	MAFK	chr6:160819690-160820028	HepG2	liver:	n/a	chr6:160819852-160819867 chr6:160819852-160819863 chr6:160819853-160819873 chr6:160819851-160819865 chr6:160819852-160819863 chr6:160819853-160819864 chr6:160819852-160819868 chr6:160819853-160819864 chr6:160819857-160819866
12	MAFF	chr6:160819693-160820048	HepG2	liver:	n/a	chr6:160819850-160819868
13	MAFK	chr6:160819679-160820046	HepG2	liver:	n/a	chr6:160819852-160819867 chr6:160819852-160819863 chr6:160819853-160819873 chr6:160819851-160819865 chr6:160819852-160819863 chr6:160819853-160819864 chr6:160819852-160819868 chr6:160819853-160819864 chr6:160819857-160819866
14	MAFK	chr6:160819730-160819986	IMR90	lung:	n/a	chr6:160819852-160819867 chr6:160819852-160819863 chr6:160819853-160819873 chr6:160819851-160819865 chr6:160819852-160819863 chr6:160819853-160819864 chr6:160819852-160819868 chr6:160819853-160819864 chr6:160819857-160819866
15	STAT3	chr6:160819719-160820044	MCF10A-Er-Src	breast:	n/a	n/a
16	MAFF	chr6:160819684-160820033	K562	blood:	n/a	chr6:160819850-160819868
17	BACH1	chr6:160819753-160819993	K562	blood:	n/a	n/a
18	FOS	chr6:160819721-160820065	MCF10A-Er-Src	breast:	n/a	chr6:160819907-160819915 chr6:160819905-160819916 chr6:160819857-160819869 chr6:160819905-160819917 chr6:160819859-160819867
19	MAFK	chr6:160819702-160820040	K562	blood:	n/a	chr6:160819852-160819867 chr6:160819852-160819863 chr6:160819853-160819873 chr6:160819851-160819865 chr6:160819852-160819863 chr6:160819853-160819864 chr6:160819852-160819868 chr6:160819853-160819864 chr6:160819857-160819866
20	FOS	chr6:160819722-160820045	MCF10A-Er-Src	breast:	n/a	chr6:160819907-160819915 chr6:160819905-160819916 chr6:160819857-160819869 chr6:160819905-160819917 chr6:160819859-160819867

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr6:160812636..160816327-chr6:160817698..160820295,4	MCF-7	breast:

Variant related genes	Relation type
ENSG00000256731	TF binding region

Extended variants
information (count: 34 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:22)

rs_ID	r²[population]
rs1567439	0.83[AMR][1000 genomes]
rs1876530	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs56126016	0.85[AMR][1000 genomes]
rs56141141	0.93[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs56196489	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs56712533	0.85[AMR][1000 genomes]
rs56862094	0.85[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs56990480	0.83[AMR][1000 genomes]
rs57128756	0.93[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs57259143	0.93[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs59516506	0.86[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs73782541	0.85[AMR][1000 genomes]
rs73782556	1.00[AMR][1000 genomes]
rs73782558	1.00[AMR][1000 genomes]
rs73782567	0.86[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs73782568	1.00[AMR][1000 genomes]
rs73782569	0.87[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs73782571	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs73782575	1.00[AFR][1000 genomes];0.83[AMR][1000 genomes]
rs73782580	0.83[AMR][1000 genomes]
rs8187718	0.85[AMR][1000 genomes]
rs9457908	1.00[AMR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:12 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	esv2758089	chr6:160372244-161234665	Weak transcription Strong transcription Active TSS Enhancers Flanking Active TSS Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	30 gene(s)	inside rSNPs	diseases
2	esv2759484	chr6:160372244-161234665	Enhancers Weak transcription Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	30 gene(s)	inside rSNPs	diseases
3	esv35098	chr6:160422589-161070870	Strong transcription Weak transcription Enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Genic enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	22 gene(s)	inside rSNPs	diseases
4	esv2757197	chr6:160432331-161070870	Weak transcription Genic enhancers Active TSS Enhancers Strong transcription Flanking Active TSS Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	19 gene(s)	inside rSNPs	diseases
5	nsv818463	chr6:160435569-161025547	Weak transcription Enhancers Active TSS Flanking Bivalent TSS/Enh Strong transcription Bivalent/Poised TSS Genic enhancers Flanking Active TSS ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	19 gene(s)	inside rSNPs	diseases
6	nsv1030746	chr6:160592321-160867031	Enhancers Bivalent/Poised TSS Genic enhancers Flanking Active TSS Strong transcription Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	5 gene(s)	inside rSNPs	diseases
7	nsv538493	chr6:160592321-160867031	Weak transcription Bivalent/Poised TSS Enhancers ZNF genes & repeats Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Strong transcription Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA	5 gene(s)	inside rSNPs	diseases
8	nsv1030171	chr6:160648469-161091864	Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Strong transcription ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	9 gene(s)	inside rSNPs	diseases
9	nsv886809	chr6:160670494-160979275	Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats Bivalent Enhancer Genic enhancers Active TSS Strong transcription Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	8 gene(s)	inside rSNPs	diseases
10	nsv886810	chr6:160700769-160897872	Enhancers Weak transcription Genic enhancers Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent/Poised TSS Strong transcription Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	4 gene(s)	inside rSNPs	diseases
11	nsv886811	chr6:160700769-161070990	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription Enhancers Flanking Active TSS Strong transcription Active TSS Bivalent Enhancer ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	7 gene(s)	inside rSNPs	diseases
12	nsv886812	chr6:160706661-161024848	Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription Active TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	6 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:36 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:160809200-160838200	Weak transcription	Fetal Muscle Trunk	muscle
2	chr6:160813400-160840600	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
3	chr6:160813600-160821200	Weak transcription	Colon Smooth Muscle	Colon
4	chr6:160813600-160829400	Weak transcription	Stomach Smooth Muscle	stomach
5	chr6:160816000-160836000	Weak transcription	HUES48 Cell Line	embryonic stem cell
6	chr6:160816000-160836800	Weak transcription	Ovary	ovary
7	chr6:160816000-160838200	Weak transcription	Placenta	Placenta
8	chr6:160816000-160840800	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
9	chr6:160816200-160820800	Weak transcription	Aorta	Aorta
10	chr6:160816200-160821400	Weak transcription	Pancreas	Pancrea
11	chr6:160816600-160820800	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
12	chr6:160816800-160827600	Weak transcription	HepG2	liver
13	chr6:160817200-160826200	Weak transcription	Liver	Liver
14	chr6:160817200-160842000	Weak transcription	Adipose Nuclei	Adipose
15	chr6:160817600-160820400	Weak transcription	Stomach Mucosa	stomach
16	chr6:160817600-160836400	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
17	chr6:160818400-160821200	Weak transcription	Skeletal Muscle Female	skeletal muscle
18	chr6:160818600-160876800	Weak transcription	Esophagus	oesophagus
19	chr6:160818800-160820200	ZNF genes & repeats	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
20	chr6:160819000-160820400	Enhancers	Hela-S3	cervix
21	chr6:160819000-160820800	Genic enhancers	A549	lung
22	chr6:160819000-160821800	Enhancers	HMEC	breast
23	chr6:160819200-160820200	Enhancers	NHEK	skin
24	chr6:160819200-160821200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
25	chr6:160819400-160820200	Enhancers	Muscle Satellite Cultured Cells	--
26	chr6:160819600-160820600	Enhancers	Psoas Muscle	Psoas
27	chr6:160819800-160820000	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
28	chr6:160819800-160820000	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
29	chr6:160819800-160820000	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
30	chr6:160819800-160820000	Flanking Active TSS	GM12878-XiMat	blood
31	chr6:160819800-160820200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
32	chr6:160819800-160820200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
33	chr6:160819800-160820200	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
34	chr6:160819800-160820200	Enhancers	Skeletal Muscle Male	skeletal muscle
35	chr6:160819800-160820200	Enhancers	HSMMtube	muscle
36	chr6:160819800-160821600	Enhancers	Primary Natural Killer cells fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links